Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.1.1.79 extracted from

  • Jones, S.E.; Whitehead, K.; Saulnier, D.; Thomas, C.M.; Versalovic, J.; Britton, R.A.
    Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition (2011), Gut Microbes, 2, 69-79.
    View publication on PubMedView publication on EuropePMC

Organism

Organism UniProt Comment Textmining
Limosilactobacillus reuteri
-
-
-
Limosilactobacillus reuteri ATCC PTA 6475
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
S-adenosyl-L-methionine + oleic acid
-
Limosilactobacillus reuteri S-adenosyl-L-homocysteine + dihydrosterculic acid
-
?
S-adenosyl-L-methionine + oleic acid
-
Limosilactobacillus reuteri ATCC PTA 6475 S-adenosyl-L-homocysteine + dihydrosterculic acid
-
?
S-adenosyl-L-methionine + vaccenic acid
-
Limosilactobacillus reuteri S-adenosyl-L-homocysteine + lactobacillic acid
-
?
S-adenosyl-L-methionine + vaccenic acid
-
Limosilactobacillus reuteri ATCC PTA 6475 S-adenosyl-L-homocysteine + lactobacillic acid
-
?

Synonyms

Synonyms Comment Organism
cyclopropane fatty acid synthase
-
Limosilactobacillus reuteri

General Information

General Information Comment Organism
malfunction mutants defective in cyclopropane fatty acid synthase are unable to suppress tumor necrosis factor production Limosilactobacillus reuteri
physiological function the enzyme suppresses tumor necrosis factor production by activated THP-1 human monocytoid cells Limosilactobacillus reuteri